• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动神经元病中的嗅觉障碍

Olfactory disorder in motor neuron disease.

作者信息

Hawkes C H, Shephard B C, Geddes J F, Body G D, Martin J E

机构信息

Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, United Kingdom.

出版信息

Exp Neurol. 1998 Apr;150(2):248-53. doi: 10.1006/exnr.1997.6773.

DOI:10.1006/exnr.1997.6773
PMID:9527894
Abstract

In Parkinson's disease and Alzheimer's disease there is profound disorder of olfaction. The extent to which this modality is involved in motor neuron disease (MND) has been studied little. To address this further we assessed olfaction by three methods-a smell identification test ("UPSIT") in 58 patients and 135 controls; olfactory-evoked response (OEP) to H2S in 15 patients, and pathological examination of olfactory bulbs obtained from 8 cadavers. It was found that smell identification compared with the controls was slightly worse overall in the MND group as a whole, but only the bulbar patients scored significantly less on the UPSIT. Patients displayed a subtle defect in cheese odor recognition. OEPs were normal in 9 subjects and delayed in 1 subject. The remaining 5 OEPs were unsuccessful. Histopathological studies of olfactory bulbs showed excess lipofuscin deposition in all 8 cases examined, indicating subclinical neuronal damage. Olfactory neurons with a degree of antioxidant defect may be more susceptible to cellular damage than other neuronal groups because of their direct relationship to environmental agents. Overall we found the degree of olfactory dysfunction in MND to be mild and in contrast with the marked changes described by others.

摘要

在帕金森病和阿尔茨海默病中,嗅觉存在严重紊乱。嗅觉在运动神经元病(MND)中的受累程度鲜有人研究。为进一步探讨这一问题,我们采用三种方法评估嗅觉:对58例患者和135名对照进行嗅觉识别测试(“UPSIT”);对15例患者进行对硫化氢的嗅觉诱发电位(OEP)测试;对8具尸体的嗅球进行病理学检查。结果发现,MND组总体上与对照组相比,嗅觉识别略差,但只有延髓型患者在UPSIT测试中的得分显著较低。患者在奶酪气味识别方面存在细微缺陷。9名受试者的OEP正常,1名受试者的OEP延迟。其余5次OEP测试未成功。嗅球的组织病理学研究显示,在所有8例检查病例中均有过量脂褐素沉积,表明存在亚临床神经元损伤。由于嗅觉神经元与环境因素直接相关,具有一定抗氧化缺陷程度的嗅觉神经元可能比其他神经元群体更容易受到细胞损伤。总体而言,我们发现MND中的嗅觉功能障碍程度较轻,与其他人描述的明显变化形成对比。

相似文献

1
Olfactory disorder in motor neuron disease.运动神经元病中的嗅觉障碍
Exp Neurol. 1998 Apr;150(2):248-53. doi: 10.1006/exnr.1997.6773.
2
Olfactory evoked responses and identification tests in neurological disease.
Ann N Y Acad Sci. 1998 Nov 30;855:608-15. doi: 10.1111/j.1749-6632.1998.tb10631.x.
3
Olfactory disfunction and its relation olfactory bulb volume in Parkinson's disease.帕金森病中的嗅觉功能障碍及其与嗅球体积的关系。
Eur Rev Med Pharmacol Sci. 2014;18(23):3659-64.
4
Olfactory dysfunction in Parkinson's disease.帕金森病中的嗅觉功能障碍。
J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46. doi: 10.1136/jnnp.62.5.436.
5
Quantitative magnetic resonance imaging evaluation of the olfactory system in Kallmann syndrome: correlation with a clinical smell test.定量磁共振成像评估 Kallmann 综合征嗅觉系统:与临床嗅觉测试的相关性。
Neuroendocrinology. 2011;94(3):209-17. doi: 10.1159/000328437. Epub 2011 May 21.
6
Olfactory acuity in chronic migraine: a cross-sectional study.慢性偏头痛患者的嗅觉敏锐度:一项横断面研究。
Headache. 2015 Jan;55(1):71-5. doi: 10.1111/head.12462. Epub 2014 Nov 11.
7
Olfactory tests in the diagnosis of essential tremor.嗅觉测试在特发性震颤诊断中的应用
Parkinsonism Relat Disord. 2008 Nov;14(7):563-8. doi: 10.1016/j.parkreldis.2007.12.006. Epub 2008 Mar 5.
8
The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction.阿尔茨海默病中的嗅球:与嗅觉相关的神经元丢失、缠结和老年斑的形态学研究
Alzheimer Dis Assoc Disord. 1994 Spring;8(1):38-48.
9
Olfactory impairment in motor neuron disease: a pilot study.运动神经元病中的嗅觉障碍:一项初步研究。
J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):927-8. doi: 10.1136/jnnp.54.10.927.
10
Do patients with motor neuron disease suffer from disorders of taste or smell?运动神经元病患者会有味觉或嗅觉障碍吗?
Amyotroph Lateral Scler. 2011 Sep;12(5):368-71. doi: 10.3109/17482968.2011.579133. Epub 2011 May 10.

引用本文的文献

1
Sensory Dysfunction in ALS and Other Motor Neuron Diseases: Clinical Relevance, Histopathology, Neurophysiology, and Insights from Neuroimaging.肌萎缩侧索硬化症及其他运动神经元疾病中的感觉功能障碍:临床相关性、组织病理学、神经生理学及神经影像学见解
Biomedicines. 2025 Feb 22;13(3):559. doi: 10.3390/biomedicines13030559.
2
Inflammation and olfactory loss are associated with at least 139 medical conditions.炎症和嗅觉丧失与至少139种疾病相关。
Front Mol Neurosci. 2024 Oct 11;17:1455418. doi: 10.3389/fnmol.2024.1455418. eCollection 2024.
3
Sensory Changes Related to Swallowing in Motor Neurone Disease.
运动神经元病中与吞咽相关的感觉变化
Dysphagia. 2025 Apr;40(2):407-418. doi: 10.1007/s00455-024-10742-x. Epub 2024 Aug 3.
4
Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases.神经退行性疾病中以边缘系统为主的与年龄相关的 TDP43 脑病(LATE)的神经病理学改变。
Nat Rev Neurol. 2023 Sep;19(9):525-541. doi: 10.1038/s41582-023-00846-7. Epub 2023 Aug 10.
5
Sensory Involvement in Amyotrophic Lateral Sclerosis.运动神经元病的感觉累及。
Int J Mol Sci. 2022 Dec 8;23(24):15521. doi: 10.3390/ijms232415521.
6
International consensus statement on allergy and rhinology: Olfaction.国际过敏与鼻科学学会共识声明:嗅觉。
Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929.
7
Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum.ALS-FTD 谱系中精神病易感性和知觉异常的神经机制。
Ann Clin Transl Neurol. 2021 Aug;8(8):1576-1591. doi: 10.1002/acn3.51363. Epub 2021 Jun 22.
8
Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.肌萎缩侧索硬化症伴随着嗅球-嗅束轴中的蛋白紊乱。
Int J Mol Sci. 2020 Nov 5;21(21):8311. doi: 10.3390/ijms21218311.
9
Olfactory dysfunction in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的嗅觉功能障碍。
Ann Clin Transl Neurol. 2018 Jun 19;5(8):976-981. doi: 10.1002/acn3.594. eCollection 2018 Aug.
10
Olfactory Dysfunction in Neurodegenerative Diseases.神经退行性疾病中的嗅觉功能障碍。
Curr Allergy Asthma Rep. 2018 Jun 15;18(8):42. doi: 10.1007/s11882-018-0796-4.